The underlying mechanisms and health risks of drug-based weight loss: central nervous system depression, accelerated metabolism, and warning signs of systemic damage.

Generally, the principles behind using weight-loss drugs for weight loss mainly include suppressing appetite, reducing the absorption of nutrients in the digestive tract, and increasing the breakdown of body fat, thereby reducing the accumulation of body fat. Although the advertising of "no exercise, no dieting" sounds very tempting, the physiological costs and health risks behind weight-loss drugs must be taken very seriously.

The drugs used in weight-loss medications can be broadly categorized into four types: the first type acts on the central nervous system to suppress appetite; the second type acts on the gastrointestinal system to reduce food absorption; the third type promotes fat burning and increases thermogenesis; and the fourth type consists of various hormonal drugs. Common specific drug components within these categories include thyroid hormones, digoxin, phentermine, fenfluramine, masindole, and orlistat.

While some medications can lead to rapid weight loss and seemingly obvious results, the risks they pose should not be underestimated. Firstly, weight-loss drugs are not only expensive but also often come with serious side effects. Once discontinued, weight rebound is often severe, sometimes even resulting in retaliatory weight gain.

Secondly, long-term use of weight-loss drugs can cause ongoing damage to the digestive and nervous systems. Many drugs can cause significant loss of appetite, persistent nausea, and diarrhea, which can lead to malnutrition over time. In severe cases, it can even lead to anemia, fractures, and gastrointestinal disorders. The chemical components produced during drug metabolism can also disrupt water and electrolyte balance, causing an imbalance in the body's internal environment.

More seriously, since most drugs need to be metabolized and excreted through the liver and kidneys, long-term use can lead to liver and kidney damage. Drug accumulation in the body may not only worsen the primary disease but also induce new pathological changes.

Furthermore, the use of weight-loss pills has strict time and frequency restrictions. Weight-loss pills usually need to be taken long-term and cannot be interrupted arbitrarily. The general recommendation is to stop for 20 to 30 days after every 6 months of use, and then resume use. Completely stopping use can easily lead to weight rebound, which is the core reason why many people who try weight-loss drugs ultimately fail.

Thyroxine is a typical example of the use of hormonal drugs. Thyroxine works by increasing the activity of glycerol phosphate oxidase in the mitochondria of fat cells, accelerating fat breakdown and promoting thermogenesis, thereby increasing the body's basal metabolic rate to achieve weight loss. However, it only produces a temporary weight loss effect and can lead to serious complications, such as inducing hyperthyroidism, osteomalacia, and heart disease. Therefore, the US FDA has officially stated that thyroid drugs should not be used to treat obesity.

To date, the medical community has not discovered any perfect weight-loss drug that can produce both lasting and effective weight loss results without any adverse reactions in the body. For those seeking healthy and long-term weight loss, relying solely on medication is tantamount to drinking poison to quench thirst. Scientific practice in exercise-based weight loss typically prohibits the use of any unproven drugs, advocating instead for a natural approach of reshaping the body through scientific exercise and a balanced diet.